Huaxin Sheng Selected Research

manganese (III) meso- tetrakis(N- ethylpyridinium- 2- yl)porphyrin

1/2021	H2O2-Driven Anticancer Activity of Mn Porphyrins and the Underlying Molecular Pathways.
2/2006	Effects of a manganese (III) porphyrin catalytic antioxidant in a mouse closed head injury model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huaxin Sheng Research Topics

Disease

19	Ischemia 01/2021 - 05/2002
17	Stroke (Strokes) 05/2022 - 10/2002
13	Brain Ischemia (Cerebral Ischemia) 01/2019 - 10/2002
10	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 05/2002
9	Ischemic Stroke 04/2022 - 06/2015
7	Heart Arrest (Cardiac Arrest) 04/2022 - 01/2018
7	Infarction (Infarctions) 01/2019 - 10/2002
7	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 02/2011 - 09/2002
6	Cerebral Infarction 01/2022 - 05/2002
6	Neurologic Manifestations (Neurological Manifestations) 01/2021 - 10/2002
5	Cerebral Hemorrhage 01/2017 - 12/2012
5	Brain Injuries (Brain Injury) 01/2016 - 12/2002
5	Hemorrhage 01/2016 - 07/2002
4	Neoplasms (Cancer) 01/2021 - 04/2011
4	Neuroinflammatory Diseases 01/2021 - 01/2016
4	Spinal Cord Injuries (Spinal Cord Injury) 06/2015 - 05/2004
4	Transient Ischemic Attack 03/2014 - 02/2008
3	Hypoxia (Hypoxemia) 05/2022 - 02/2006
3	Wounds and Injuries (Trauma) 01/2021 - 04/2011
3	Inflammation (Inflammations) 08/2020 - 07/2010
3	Hypotension (Low Blood Pressure) 01/2020 - 11/2003
3	Brain Edema (Cerebral Edema) 01/2016 - 01/2006
3	Spinal Cord Compression 06/2015 - 05/2004
2	Central Nervous System Diseases (CNS Diseases) 01/2022 - 05/2014
2	Lymphopenia (Lymphocytopenia) 01/2021 - 01/2021
2	Atrophy 01/2021 - 01/2021
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 11/2015
2	Body Weight (Weight, Body) 01/2019 - 07/2014
2	Hematoma 01/2016 - 07/2014
2	Hypothermia 12/2012 - 05/2002
2	Thrombosis (Thrombus) 02/2011 - 02/2003
2	Closed Head Injuries 02/2006 - 01/2006
2	Intracranial Vasospasm 12/2002 - 09/2002
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2022
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 07/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Asphyxia (Suffocation) 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Anus Neoplasms (Anal Cancer) 01/2021
1	Glioma (Gliomas) 01/2021

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 07/2022 - 12/2002
6	PorphyrinsIBA 01/2021 - 02/2006
6	UbiquitinIBA 02/2016 - 05/2008
6	AntioxidantsIBA 04/2011 - 10/2002
4	Pharmaceutical PreparationsIBA 01/2020 - 11/2015
4	Anesthetics (Anesthetic Agents)IBA 10/2016 - 11/2003
4	Isoflurane FDA LinkGeneric 01/2007 - 11/2003
3	salicylhydroxamic acid (SHAM)IBA 01/2021 - 04/2014
3	Oxygen (Dioxygen)IBA 01/2021 - 02/2012
3	CytokinesIBA 01/2021 - 01/2016
3	Superoxides (Superoxide)IBA 05/2014 - 09/2002
3	Fentanyl (Sublimaze)FDA LinkGeneric 07/2006 - 11/2003
3	AEOL 10150IBA 08/2004 - 10/2002
2	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2020
2	Neuroprotective AgentsIBA 01/2022 - 01/2016
2	manganese (III) meso- tetrakis(N- ethylpyridinium- 2- yl)porphyrinIBA 01/2021 - 02/2006
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021 - 10/2018
2	thiamet GIBA 01/2021 - 01/2017
2	Therapeutic UsesIBA 01/2021 - 01/2013
2	Tamoxifen FDA LinkGeneric 01/2020 - 03/2017
2	hydroxide ionIBA 01/2020 - 05/2013
2	NitrogenIBA 01/2019 - 09/2004
2	Protein Isoforms (Isoforms)IBA 01/2018 - 01/2006
2	CreatinineIBA 01/2018 - 02/2013
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 02/2008
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 02/2012
2	Progesterone FDA LinkGeneric 01/2016 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 07/2010
2	Superoxide DismutaseIBA 11/2015 - 09/2002
2	ManganeseIBA 11/2015 - 08/2004
2	Apolipoproteins E (ApoE)IBA 07/2014 - 01/2006
2	MetalloporphyrinsIBA 05/2014 - 10/2002
2	Peroxynitrous Acid (Peroxynitrite)IBA 05/2014 - 04/2011
2	ProteomeIBA 04/2014 - 03/2014
2	Hemoglobins (Hemoglobin)IBA 02/2011 - 05/2002
2	Simvastatin (Zocor)FDA LinkGeneric 10/2009 - 12/2002
2	Dichlorodiphenyldichloroethane (DDD)IBA 10/2009 - 08/2004
2	Nitrous Oxide (Laughing Gas)IBA 07/2006 - 05/2004
2	manganese(III) porphyrinIBA 02/2006 - 08/2004
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2002 - 10/2002
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2022
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 05/2022
1	Small Cytoplasmic RNAIBA 04/2022
1	Antigen-Antibody Complex (Immune Complex)IBA 04/2022
1	Glucosamine (Dona)IBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	Activating Transcription Factor 6IBA 01/2021
1	Uridine Diphosphate (UDP)IBA 01/2021
1	Mifepristone (RU 486)FDA Link 01/2021
1	InterleukinsIBA 08/2020
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 08/2020

Therapy/Procedure

7	Therapeutics 01/2022 - 08/2004
6	Resuscitation 11/2021 - 01/2018
3	Cardiopulmonary Resuscitation (CPR) 01/2021 - 01/2018
2	Vagus Nerve Stimulation 04/2022 - 01/2022
2	Transplantation 01/2017 - 04/2007
2	Anesthesia 10/2016 - 05/2004
2	Duration of Therapy 12/2012 - 10/2009
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 08/2011 - 07/2010
1	Electric Stimulation Therapy (Electrotherapy) 01/2022